Details for New Drug Application (NDA): 050405
✉ Email this page to a colleague
NDA 050405 describes KEFLEX, which is a drug marketed by Pragma and is included in two NDAs. Additional details are available on the KEFLEX profile page.
The generic ingredient in KEFLEX is cephalexin. There are twenty-nine drug master file entries for this compound. Thirty-seven suppliers are listed for this compound. Additional details are available on the cephalexin profile page.
The generic ingredient in KEFLEX is cephalexin. There are twenty-nine drug master file entries for this compound. Thirty-seven suppliers are listed for this compound. Additional details are available on the cephalexin profile page.
Summary for 050405
| Tradename: | KEFLEX |
| Applicant: | Pragma |
| Ingredient: | cephalexin |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 050405
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | EQ 250MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | Yes | |||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | EQ 500MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | Yes | |||||
Profile for product number 004
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | EQ 333MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | May 12, 2006 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
